Tadalafil citrate (DrugBank: Tadalafil)
7 diseasesID | Disease name (Link within this page) | Number of trials |
---|---|---|
6 | Parkinson disease | 0 |
51 | Scleroderma | 0 |
75 | Cushing disease | 0 |
84 | Sarcoidosis | 0 |
86 | Pulmonary arterial hypertension | 0 |
113 | Muscular dystrophy | 0 |
210 | Single Ventricle | 1 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01291069 (ClinicalTrials.gov) | September 2011 | 4/2/2011 | Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients | Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients | Single Ventricle | Drug: Tadalafil Citrate;Drug: Sugar pill | University of Utah | NULL | Completed | 8 Years | 35 Years | All | 20 | Phase 1 | United States |